Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Deven Parmar
Observed name:
Deven V. Parmar
Institutions:
Zydus Lifesciences Limited (India),
Zydus Therapeutics Inc. (United States)
Observed institutions:
Zydus Lifesciences Limited (India),
Zydus Therapeutics Inc. (United States)
ORCID:
0000-0002-9795-2360
Observed ORCID:
0000-0002-9795-2360
OpenAlex ID:
A5099687237
EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitis
2026
·
Cynthia Levy
, Ana Lleo
, et al.
·
Journal of Hepatology
·
11
Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment
2024
·
Raj Vuppalanchi
, Mary M. Cruz
, et al.
·
Clinical Pharmacology & Therapeutics
·
10
PDF
Saroglitazar 4 Mg in Metabolic Dysfunction‐Associated Steatotic Liver Disease: 24‐Week Results From Phase 4 Study
2026
·
Arun Sanyal
, Soham Doshi
, et al.
·
Liver International
·
5
The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients
2024
·
Kung-Hung Lin
, Nuria Amigo
, et al.
·
Clínica e Investigación en Arteriosclerosis (English Edition)
·
3
LBO-001 A phase 2b/3 trial of saroglitazar in primary biliary cholangitis (EPICS III)
2026
·
Raj Vuppalanchi
, Alejandra Villamil
, et al.
·
Journal of Hepatology
·
1
Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial
2026
·
Prabhat Kumar Sharma
, Sagar Vivek Redkar
, et al.
·
Metabolism Open
·
1
A Phase 3 Randomized Controlled Trial of Fixed-Dose Vilanterol/Umeclidinium/Fluticasone Furoate Versus Indacaterol/Glycopyrronium/Mometasone Furoate Dry Powder Inhalers in Indian Adults With Asthma
2026
·
Pankaj Vyas
, Mitul Chaudhari
, et al.
·
Cureus
PDF
Vilanterol/Umeclidinium versus Vilanterol/Glycopyrronium via Metered-Dose or Dry-Powder Inhaler in Indian Adults with COPD: Two Randomized Phase III Non-Inferiority Trials
2026
·
Pankaj Bharat Bhai Vyas
, Mitul Kumar Manubhai Chaudhari
, et al.
·
Respiratory Medicine
A phase 2b/3 trial of saroglitazar in primary biliary cholangitis
2026
·
Raj Vuppalanchi
, Alejandra Villamil
, et al.
·
Hepatology
Efficacy and Safety of Revefenacin Versus Glycopyrronium in Indian Chronic Obstructive Pulmonary Disease (COPD) Patients: A Randomized, Active-Controlled, Phase III Trial
2026
·
Aman Ashokkumar Ahuja
, Manish Kumar Mahendra Singh Jain
, et al.
·
Cureus
PDF
Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled study
2026
·
Niharika Samala
, José González-González
, et al.
·
Hepatology
Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP
2026
·
Karthik Venkatakrishnan
, Abhigyan Ravula
, et al.
·
The Journal of Clinical Pharmacology
PDF
A Phase IIa , Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease
2026
·
Mohit Desai
, Bhargav Solanki
, et al.
·
European Journal Of Haematology
PDF
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
2026
·
Prabhat Kumar Sharma
, V. Viswaprasad
, et al.
·
Metabolism Open
Corrigendum to “Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial” [Metabol Open 30 (2026) 100460]
2026
·
Prabhat Kumar Sharma
, Sagar Vivek Redkar
, et al.
·
Metabolism Open
Wcn26-390 a Phase-4, 52-week, Single Arm, Post-marketing Surveillance to Evaluate Safety of Desidustat for Treatment of Anemia in Subjects With Chronic Kidney Disease
2026
·
Prakash Khetan
, Hardik Shah
, et al.
·
Kidney International Reports
A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea® in Patients with Wet Age-Related Macular Degeneration
2026
·
Mudit Bansal
, Punit Singh
, et al.
·
Ophthalmology and Therapy
PDF
Antigen specific T cell responses and cytokine production in healthy subjects following a recombinant hepatitis E vaccine 3545
2025
·
Fareha Umam
, Rituparna Jana
, et al.
·
The Journal of Immunology
PDF
SAT-668 Saroglitazar Improves Hepatic Steatosis And Liver Enzymes In Women With PCOS And MASLD: Results Of Evidences VII Randomized Control Study
2025
·
Deven Parmar
, Niharika Samala
, et al.
·
Journal of the Endocrine Society
PDF
Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants
2025
·
Songa Narayana Rao
, Deepali Ambike
, et al.
·
Viruses
PDF
Show more works
View as search
Works count:
20
Citation count:
31
H-index:
3
I10-index:
2
Year
Topic
Type